- Coordinator
- Politecnico Di Milano, Italy
- Runs
- 1 January 2023 to 31 March 2027
- Status
- Running
- EU funding
- €2.6m
- Total cost
- —
- Partners
- 24 organisations in 12 countries
- Type
- Marie Skłodowska-Curie Action
- Grant agreement
- 101073089
What the project is doing
In the project's own words, from its summary on CORDIS.
Greening and digitalizing pharmaceutical manufacturing is one of the grand challenges of Europe's pharma-industry. It offers a significant opportunity to boost productivity, improve competitiveness and reduce the industry large environmental footprint. Current progress is impaired by shortage of trained engineers and scientists, who can design green and digital pharmaceutical processes. This MSCA doctoral network will focus on addressing these skills gaps, delivering a cohort of highly-skilled and trained PhD graduates that will lead the green and digital transformation of the pharmaceutical manufacturing, both in academic and industrial environments.
The consortium brings together 7 universities, 1 research center, and additional 11 associated members from academia and industry. This will address urgent topics in continuous green manufacturing and develop greener routes to prepare pharmaceutical products, promoting the adoption of novel technologies (flow synthesis instead batch methods, heterogeneous nano and biocatalysis in lieu of homogeneous catalysts, renewable carbon sources, novel purification methods, digitalization tools) for sustainable manufacturing.
Specific PhD topics for 10 ESRs have been outlined. The research and training programme will equip the ESRs with key scientific and transferable skills, such as IPR, entrepreneurship, data and innovation management. The consortium strong track record in the management of interdisciplinary research and training will ensure effective and timely training of the next-generation leaders of Europe’s pharma-industries. The exposure to academic and industry sectors will also provide the researchers with unparalleled career opportunities.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Politecnico Di Milano | Milano | Italy | Coordinator |
| Universiteit Gent | Gent | Belgium | Participant |
| Vlaamse Instelling Voor Technologisch Onderzoek N.v. | Mol | Belgium | Participant |
| Universidade Estadual De Campinas | Campinas Sp | Brazil | Associatedpartner |
| Chromacon AG | Zurich | Switzerland | Associatedpartner |
| Datahow AG | Zurich | Switzerland | Associatedpartner |
| Deasyl SA | Plan Les Ouates | Switzerland | Associatedpartner |
| Dalian University of Technology | Dalian | China | Associatedpartner |
| Universidad De Cordoba | Cordoba | Spain | Participant |
| Dompe Farmaceutici SpA | Milano | Italy | Associatedpartner |
| Procos Spa | Cameri | Italy | Associatedpartner |
| Universita Degli Studi Di Bari Aldo Moro | Bari | Italy | Participant |
| Universita Degli Studi Di Milano | Milano | Italy | Associatedpartner |
| C2cat BV | Ter Aar | Netherlands | Associatedpartner |
| Feyecon Development & Implementation BV | Weesp | Netherlands | Associatedpartner |
| Symeres Netherlands BV | Nijmegen | Netherlands | Associatedpartner |
| Universiteit Van Amsterdam | Amsterdam | Netherlands | Participant |
| King Faisal University | Al Hofouf | SA | Associatedpartner |
| Astrazeneca AB | Sodertaelje | Sweden | Associatedpartner |
| Sartorius Bia Separations, Separacijske Tehnologije, D.o.o. | Ajdovscina | Slovenia | Associatedpartner |
| Univerza V Ljubljani | Ljubljana | Slovenia | Participant |
| Loughborough University | Loughborough | United Kingdom | Associatedpartner |
| Uniqsis Ltd | Shepreth | United Kingdom | Associatedpartner |
| Lawrence Berkeley National Laboratory - Accelerator Technology and Applied Physics Division | Berkeley | United States | Associatedpartner |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI